UNFO Med is the developer of the Universal Neonatal Foot Orthotics (UNFO) device, a child-friendly corrective foot brace developed specifically for the effective, safe, and stress-free treatment of metatarsus adductus (MTA) in newborns.

The UNFO brace addresses the difficulties and stress of frequent casting, the ineffectiveness of stretching, and the resulting under-treatment or over-treatment of MTA and clubfoot.UNFO has clients in Israel, Italy, Africa, Ukraine, and South Korea, and has received FDA approval in the United States and CE mark approval in Europe.